Pruritus
Conditions
Keywords
pruritus, itching, mexyn-a, clearitch, magicool-plus
Brief summary
Atomised Methoxymethane-in-Aqua (MEXYN-A) a new topical self-chilled, non-steroidal, non-flammable, pressurised spray which embodies in one simultaneous application, most of the currently recognised and effective chemical, mechanical and thermal anti-pruritic therapies and hydrotherapy.
Detailed description
The primary clinical endpoint was to establish MEXYN-A efficacy and safety in abolishing or reducing pruritus related to cutaneous diseases, insect bites and poison ivy, within few seconds of the application. The secondary endpoint was to measure the itch free period as a result of the new intervention.
Interventions
DEVICEMexyn-A
Atomised topical self-chilled pressurised spray
Sponsors
Evangelical Synod Medical Centre
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
5 Years to 80 Years
Healthy volunteers
Yes
Inclusion criteria
* Patients suffering from severe itching due to : Atopic Dermatitis, contact dermatitis, psoriasis, urticaria, xerosis, prickly heat, genital pruritus, chicken pox, aquagenic pruritus, lichen planus, poison ivey, insect bites. * Past experience with the use of at least one conventional medication for pruritus or conventional medication for the same disorder patients suffered.
Exclusion criteria
* Patients who have taken any anti-pruritic drug during the month prior to participation. * Patients who have taken drugs for any reason for 2 days prior to participating in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treating Pruritus | three days |
Secondary
| Measure | Time frame |
|---|---|
| measuring itch-free period after applying the new treatment, effect on sleep disturbance | three days |
Countries
Egypt
Outcome results
None listed